Newbridge Financial Services Group’s Ascendis Pharma A/S ASND Stock Holding History

Newbridge Financial Services Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25	Closed	-$2.34K	–	1154
2023 Q3	$2.34K	Hold	25	–	–	﹤0.01%	1054
2023 Q2	$2.23K	Hold	25	–	–	﹤0.01%	1123
2023 Q1	$2.68K	Hold	25	–	–	﹤0.01%	1157
2022 Q4	$3.05K	Hold	25	–	–	﹤0.01%	1151
2022 Q3	$3K	Hold	25	–	–	﹤0.01%	1111
2022 Q2	$2K	Hold	25	–	–	﹤0.01%	1151
2022 Q1	$3K	Hold	25	–	–	﹤0.01%	1177
2021 Q4	$3K	Hold	25	–	–	﹤0.01%	1139
2021 Q3	$4K	Hold	25	–	–	﹤0.01%	1041
2021 Q2	$3K	Hold	25	–	–	﹤0.01%	1198
2021 Q1	$3K	Buy	+25	New	+$3.8K	﹤0.01%	1102

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Newbridge Financial Services Group's ASND Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Ascendis Pharma A/S (ASND) in Q4 2023, closing a stake of 25 shares — an estimated $2.34K sold.

Newbridge Financial Services Group first reported a position in ASND in Q1 2021 and held it in 11 quarters. The position peaked at $4K in Q3 2021. 185 funds tracked by Wall St. Rank hold ASND as of Q4 2023.

Newbridge Financial Services Group reported no remaining Ascendis Pharma A/S position as of Q4 2023 after selling out during the quarter.
Newbridge Financial Services Group sold 25 Ascendis Pharma A/S shares in Q4 2023, an estimated $2.34K.
Newbridge Financial Services Group first reported a position in Ascendis Pharma A/S in Q1 2021 and held it in 11 quarters.
Newbridge Financial Services Group's Ascendis Pharma A/S position peaked at $4K in Q3 2021.
185 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.